Akero Therapeutics
AKRO
AKRO
79 hedge funds and large institutions have $545M invested in Akero Therapeutics in 2020 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 33 increasing their positions, 18 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.86% less ownership
Funds ownership: 77.1% → 76.24% (-0.86%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
76% less call options, than puts
Call options by funds: $206K | Put options by funds: $869K
Holders
79
Holding in Top 10
3
Calls
$206K
Puts
$869K
Top Buyers
| 1 | +$7.72M | |
| 2 | +$5.82M | |
| 3 | +$4.12M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$3.44M |
| 5 |
Morgan Stanley
New York
|
+$3.35M |
Top Sellers
| 1 | -$15.5M | |
| 2 | -$6.98M | |
| 3 | -$6M | |
| 4 |
VC
Vivo Capital
Palo Alto,
California
|
-$5.41M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$4.42M |